CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.57
-0.25 (-3.20%)
At close: Apr 28, 2026, 4:00 PM EDT
7.70
+0.13 (1.72%)
Pre-market: Apr 29, 2026, 7:31 AM EDT
CorMedix Stock Forecast
Stock Price Forecast
The 6 analysts that cover CorMedix stock have a consensus rating of "Strong Buy" and an average price target of $14.83, which forecasts a 95.90% increase in the stock price over the next year. The lowest target is $13 and the highest is $19.
Price Target: $14.83 (+95.90%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CorMedix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +84.94% | Apr 28, 2026 |
| Citizens | Citizens | Buy Reiterates $19 | Buy | Reiterates | $19 | +150.99% | Apr 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +84.94% | Apr 28, 2026 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +98.15% | Apr 27, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +84.94% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
312.65M
from 311.71M
Increased by 0.30%
Revenue Next Year
295.89M
from 312.65M
Decreased by -5.36%
EPS This Year
0.85
from 2.04
Decreased by -58.46%
EPS Next Year
0.69
from 0.85
Decreased by -18.88%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 329.2M | 337.0M | ||||||
| Avg | 312.7M | 295.9M | ||||||
| Low | 288.6M | 260.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5.6% | 7.8% | ||||||
| Avg | 0.3% | -5.4% | ||||||
| Low | -7.4% | -16.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.32 | 1.16 | ||||||
| Avg | 0.85 | 0.69 | ||||||
| Low | 0.42 | 0.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -35.4% | 36.3% | ||||||
| Avg | -58.5% | -18.9% | ||||||
| Low | -79.3% | -71.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.